Intensity Modulated Radiation Therapy for Head and Neck Cancer

• Status: Completed
• Trial end date: 2019-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Many normal tissues, including the eyes, brain, and spinal cord are very close to cancers in the nasopharynx. The dose of radiation delivered to the cancer is limited by tolerance of these normal tissues. Standard radiation treatment techniques using three or four radiation beams cannot avoid delivering some dose of radiation to these normal tissues that do not need to get radiation. Intensity Modulated Radiation Therapy (IMRT) uses many hundreds of computer-controlled radiation beams aimed at your cancer to try to lower the amount of radiation that normal tissues receive, while still delivering the desired amount of radiation to your cancer and to areas that your doctor thinks may have cancer cells.

The doctors at Princess Margaret Hospital are conducting this study in order to test whether the use of IMRT techniques can improve the chance of controlling your cancer in the head and neck region.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Health Network, Toronto
• Collaborator: Princess Margaret Hospital, Canada
• Treatments: Fluorouracil

Criteria

Inclusion Criteria:

• Confirmed histopathologic diagnosis of nasopharyngeal squamous cell carcinoma requiring primary radiation

• less than 70 yrs of age

• Stage T1-T4; N0-N3; M0

• KPS less than 70

• no prior RT to H&N or chemotherapy for H&N

• no other malignancy except non-melanomatous skin cancer

• no distant mets

• no contraindication to RT or chemotherapy

• adequate organ function

• informed consent

Exclusion Criteria

• Major medical or psychiatric illness, which would interfere with either completion of therapy and follow-up or with full and complete understanding of the risks and potential complications of the therapy.